The recent identification of a patient with syndromic thrombocytopenia due to a germline heterozygous RAP1B-G12E variant (P2 in Table 3) (36) clearly illustrates the deleterious effect of this variant in a wide range of tissues. This evidence concerns the gene RAP1B and Thrombocytopenia.